C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China
· Delayed Price · Currency is CNY 5.79
+0.12 (2.12%)
At close: Mar 6, 2026
SHE:000950 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 82,773 | 80,255 | 78,185 | 67,657 | 62,354 | 45,104 | Upgrade
|
| Other Revenue | 307.01 | 307.01 | 212.62 | 171.83 | 166.87 | 115.37 | Upgrade
|
| Revenue | 83,080 | 80,562 | 78,397 | 67,829 | 62,521 | 45,220 | Upgrade
|
| Revenue Growth (YoY) | 4.23% | 2.76% | 15.58% | 8.49% | 38.26% | 33.61% | Upgrade
|
| Cost of Revenue | 77,109 | 74,641 | 72,162 | 62,038 | 56,817 | 41,012 | Upgrade
|
| Gross Profit | 5,971 | 5,921 | 6,235 | 5,791 | 5,703 | 4,207 | Upgrade
|
| Selling, General & Admin | 3,819 | 3,967 | 3,678 | 3,298 | 3,078 | 2,218 | Upgrade
|
| Research & Development | -8.14 | 0.32 | 0.38 | 3.24 | 10.04 | 2.67 | Upgrade
|
| Other Operating Expenses | 218.21 | 189.22 | 212.55 | 188.63 | 155.73 | 123.62 | Upgrade
|
| Operating Expenses | 4,780 | 4,688 | 4,279 | 3,614 | 3,526 | 2,446 | Upgrade
|
| Operating Income | 1,191 | 1,232 | 1,957 | 2,177 | 2,177 | 1,762 | Upgrade
|
| Interest Expense | -863.54 | -1,138 | -1,340 | -1,123 | -1,106 | -675.52 | Upgrade
|
| Interest & Investment Income | 367.06 | 488.19 | 393.27 | 355.29 | 347.92 | 325.03 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.17 | -0.17 | 0.18 | 0.44 | -0.1 | 0.43 | Upgrade
|
| Other Non Operating Income (Expenses) | -46.96 | -41.03 | -103.03 | -12.36 | 3.66 | -104.4 | Upgrade
|
| EBT Excluding Unusual Items | 647.78 | 541.54 | 906.96 | 1,397 | 1,423 | 1,307 | Upgrade
|
| Impairment of Goodwill | -40.22 | -40.22 | -20.48 | -27.91 | -10.32 | -14.68 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.99 | 6.92 | 16.16 | 2.32 | 126.88 | 17.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | 11.23 | 10.53 | 0.79 | 10.05 | 3.52 | 21.54 | Upgrade
|
| Asset Writedown | -10.06 | 0.01 | -0.01 | -0.02 | -0.35 | - | Upgrade
|
| Other Unusual Items | 60.12 | 38.73 | 62.91 | 91.25 | 37.35 | 42.89 | Upgrade
|
| Pretax Income | 667.86 | 557.51 | 966.33 | 1,472 | 1,580 | 1,374 | Upgrade
|
| Income Tax Expense | 140.54 | 155.72 | 236.04 | 309.5 | 289.61 | 227.07 | Upgrade
|
| Earnings From Continuing Operations | 527.33 | 401.79 | 730.29 | 1,163 | 1,291 | 1,147 | Upgrade
|
| Net Income to Company | 527.33 | 401.79 | 730.29 | 1,163 | 1,291 | 1,147 | Upgrade
|
| Minority Interest in Earnings | -152.55 | -118.8 | -105.65 | -210.72 | -285.23 | -263.05 | Upgrade
|
| Net Income | 374.78 | 282.99 | 624.63 | 952.28 | 1,005 | 884.34 | Upgrade
|
| Net Income to Common | 374.78 | 282.99 | 624.63 | 952.28 | 1,005 | 884.34 | Upgrade
|
| Net Income Growth | -6.13% | -54.69% | -34.41% | -5.29% | 13.69% | 12.22% | Upgrade
|
| Shares Outstanding (Basic) | 1,789 | 1,769 | 1,735 | 1,731 | 1,734 | 1,728 | Upgrade
|
| Shares Outstanding (Diluted) | 1,789 | 1,769 | 1,735 | 1,731 | 1,734 | 1,728 | Upgrade
|
| Shares Change (YoY) | 3.37% | 1.94% | 0.21% | -0.12% | 0.31% | - | Upgrade
|
| EPS (Basic) | 0.21 | 0.16 | 0.36 | 0.55 | 0.58 | 0.51 | Upgrade
|
| EPS (Diluted) | 0.21 | 0.16 | 0.36 | 0.55 | 0.58 | 0.51 | Upgrade
|
| EPS Growth | -9.19% | -55.56% | -34.54% | -5.17% | 13.73% | 11.85% | Upgrade
|
| Free Cash Flow | 324.79 | -437.27 | 264.13 | 17.76 | -239.38 | 253.82 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | -0.25 | 0.15 | 0.01 | -0.14 | 0.15 | Upgrade
|
| Dividend Per Share | 0.060 | 0.060 | 0.050 | 0.060 | 0.105 | - | Upgrade
|
| Dividend Growth | -25.00% | 20.00% | -16.67% | -42.86% | - | - | Upgrade
|
| Gross Margin | 7.19% | 7.35% | 7.95% | 8.54% | 9.12% | 9.30% | Upgrade
|
| Operating Margin | 1.43% | 1.53% | 2.50% | 3.21% | 3.48% | 3.90% | Upgrade
|
| Profit Margin | 0.45% | 0.35% | 0.80% | 1.40% | 1.61% | 1.96% | Upgrade
|
| Free Cash Flow Margin | 0.39% | -0.54% | 0.34% | 0.03% | -0.38% | 0.56% | Upgrade
|
| EBITDA | 1,438 | 1,479 | 2,203 | 2,408 | 2,346 | 1,886 | Upgrade
|
| EBITDA Margin | 1.73% | 1.84% | 2.81% | 3.55% | 3.75% | 4.17% | Upgrade
|
| D&A For EBITDA | 246.4 | 246.6 | 246.87 | 231.17 | 169.06 | 124.75 | Upgrade
|
| EBIT | 1,191 | 1,232 | 1,957 | 2,177 | 2,177 | 1,762 | Upgrade
|
| EBIT Margin | 1.43% | 1.53% | 2.50% | 3.21% | 3.48% | 3.90% | Upgrade
|
| Effective Tax Rate | 21.04% | 27.93% | 24.43% | 21.02% | 18.33% | 16.52% | Upgrade
|
| Revenue as Reported | 83,080 | 80,562 | 78,397 | 67,829 | 62,521 | 45,220 | Upgrade
|
| Advertising Expenses | - | 9.42 | 9.57 | 20.39 | 23.49 | 14.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.